Alto Neuroscience (ANRO) Stock Chart & Stock Price History $2.58 -0.10 (-3.73%) Closing price 07/15/2025 03:59 PM EasternExtended Trading$2.56 -0.02 (-0.58%) As of 07/15/2025 06:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Alto Neuroscience Stock Price Performance The Alto Neuroscience (ANRO) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 83.35%, with a year-to-date return of -39.01%. In the past month, the stock has increased 11.45%, reflecting recent market activity. As of the latest close, Alto Neuroscience traded at $2.58 with a market cap of $69.84 million and volume of 93,410 shares. Receive ANRO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Alto Neuroscience and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.96%1 Month Performance+11.45%3 Month Performance+15.18%Year-To-Date Performance-39.01%1 Year Performance-83.35% ANRO Stock Chart for Wednesday, July, 16, 2025 ANRO Chart by TradingView Alto Neuroscience Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/15/2025$2.71$2.58-4.62%$2.74$2.5393,410 shs$69.84 million07/14/2025$2.61$2.71+3.84%$2.74$2.5795,234 shs$73.22 million07/11/2025$2.62$2.61-0.57%$2.66$2.5068,295 shs$70.52 million07/10/2025$2.65$2.62-1.13%$2.67$2.5474,117 shs$70.92 million07/09/2025$2.50$2.65+6.00%$2.74$2.50184,278 shs$71.74 million07/08/2025$2.30$2.50+8.70%$2.53$2.29227,494 shs$67.68 million07/07/2025$2.35$2.30-1.92%$2.38$2.2887,959 shs$62.26 million07/04/2025$2.35$2.35$2.40$2.2783,674 shs$63.48 million07/03/2025$2.33$2.35+0.64%$2.40$2.2783,674 shs$63.48 million07/02/2025$2.22$2.33+5.05%$2.41$2.22189,628 shs$63.07 million Get the Latest News and Ratings for ANRO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alto Neuroscience and its competitors with MarketBeat's FREE daily newsletter. 07/01/2025$2.21$2.22+0.36%$2.28$2.20199,860 shs$60.04 million06/30/2025$2.35$2.21-5.76%$2.33$2.15390,164 shs$59.83 million06/27/2025$2.31$2.35+1.74%$2.49$2.292.61 million shs$63.48 million06/26/2025$2.59$2.31-10.83%$2.62$2.25720,989 shs$62.40 million06/25/2025$2.52$2.59+2.58%$2.65$2.39214,215 shs$69.98 million06/24/2025$2.37$2.52+6.55%$2.57$2.37235,132 shs$68.22 million06/23/2025$2.22$2.37+6.53%$2.47$2.20591,542 shs$64.02 million06/20/2025$2.26$2.22-1.77%$2.27$2.15457,397 shs$60.10 million06/19/2025$2.26$2.26$2.33$2.21149,415 shs$61.18 million06/18/2025$2.24$2.26+0.89%$2.33$2.21149,415 shs$61.18 million06/17/2025$2.32$2.24-3.24%$2.36$2.23227,741 shs$60.64 million06/16/2025$2.42$2.32-4.14%$2.42$2.25205,783 shs$62.67 million Related Companies Sagimet Biosciences Stock Chart Prima BioMed Stock Chart Cardiff Oncology Stock Chart Adherex Technologies Stock Chart Vor Biopharma Stock Chart Inhibrx Biosciences Stock Chart Canopy Growth Stock Chart Liminatus Pharma Stock Chart Esperion Therapeutics Stock Chart biote Stock Chart Receive ANRO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Alto Neuroscience and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:ANRO) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alto Neuroscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alto Neuroscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
